Processing

Please wait...

Settings

Settings

Goto Application

1. WO2007034510 - DERIVATIVES OF 4,6-DISUBSTITUTED 1,2,4-TRIAZOLO-1,3,4-THIADIAZOLE, A PROCESS AND USES THEREOF

Publication Number WO/2007/034510
Publication Date 29.03.2007
International Application No. PCT/IN2006/000379
International Filing Date 20.09.2006
IPC
C07D 513/04 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
513Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/, C07D477/232
02in which the condensed system contains two hetero rings
04Ortho-condensed systems
A61K 31/41 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
A61K 31/433 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
433Thiadiazoles
A61K 31/4196 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
41961,2,4-Triazoles
CPC
A61P 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
C07D 513/04
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
513Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
02in which the condensed system contains two hetero rings
04Ortho-condensed systems
Applicants
  • JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH [IN]/[IN] (AllExceptUS)
  • UNIVERSITY OF MYSORE [IN]/[IN] (AllExceptUS)
  • KUNDU, Tapas, Kumar [IN]/[IN] (UsOnly)
  • RANGAPPA, Kanchugarakoppal, Subbegowda [IN]/[IN] (UsOnly)
  • SAILAJA, Badi, Sri [IN]/[IN] (UsOnly)
  • VARIER, Radhika, Ashish [IN]/[IN] (UsOnly)
  • SHIVANANJU, Nanjundaswamy [IN]/[IN] (UsOnly)
  • BASAPPA, [IN]/[IN] (UsOnly)
Inventors
  • KUNDU, Tapas, Kumar
  • RANGAPPA, Kanchugarakoppal, Subbegowda
  • SAILAJA, Badi, Sri
  • VARIER, Radhika, Ashish
  • SHIVANANJU, Nanjundaswamy
  • BASAPPA,
Agents
  • BHOLA, Ravi
Priority Data
1341/CHE/200521.09.2005IN
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) DERIVATIVES OF 4,6-DISUBSTITUTED 1,2,4-TRIAZOLO-1,3,4-THIADIAZOLE, A PROCESS AND USES THEREOF
(FR) DERIVES DE 4,6-BISUBSTITUE 1,2,4-TRIAZOLO-1,3,4-THIADIAZOLE, PROCEDE DE SYNTHESE DE CES DERNIERS ET UTILISATIONS CORRESPONDANTES
Abstract
(EN)
The present invention is in relation to the derivatives of 4,6-disubstituted 1,2,4-triazolo-1, 3, 4-thiadiazole and a process to synthesize the said derivatives. Also, the present invention was able to establish the activity of the instant derivatives against anti-cancerous activity specific to cervical and oral cancer.
(FR)
La présente invention porte sur les dérivés de 4,6-bisubstitué 1,2,4-triazolo-1, 3, 4-thiadiazole et sur un procédé de synthèse desdits dérivés. Cette invention a également permis d'établir l'activité des dérivés selon l'invention en liaison avec l'activité anticancéreuse spécifique au cancer du col de l'utérus et au cancer de la bouche.
Latest bibliographic data on file with the International Bureau